NEFL and cerebral small vessel disease: While NfL could not draw meaningful conclusions due to the different units of statistical analysis in this meta-analysis, it is not yet possible to conclude that Lp-PLA2 is a potential biomarker of cognitive impairment in cerebral small vessel disease.